| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 33.749 | 45.591 | 55.738 | 53.009 | 75.302 | 86.979 | 119.825 | 94.419 | 127.672 |
| Total Income - EUR | 0 | 33.782 | 45.606 | 55.758 | 53.022 | 75.312 | 86.992 | 119.831 | 94.421 | 127.683 |
| Total Expenses - EUR | 1.167 | 18.183 | 29.036 | 25.489 | 36.130 | 40.477 | 48.901 | 55.797 | 84.702 | 91.563 |
| Gross Profit/Loss - EUR | -1.167 | 15.599 | 16.570 | 30.270 | 16.891 | 34.834 | 38.092 | 64.034 | 9.719 | 36.120 |
| Net Profit/Loss - EUR | -1.167 | 14.924 | 16.114 | 29.713 | 16.361 | 34.138 | 37.326 | 63.016 | 8.917 | 32.558 |
| Employees | 0 | 2 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Oftalroxmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.313 | 25.367 | 30.407 | 28.374 | 199.030 | 200.302 | 358.379 | 462.550 | 466.321 | 494.339 |
| Current Assets | 67 | 19.945 | 31.690 | 25.725 | 9.112 | 33.229 | 21.078 | 46.088 | 27.543 | 36.849 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 2.874 | 3.389 | 4.511 | 98 | 2.289 | 4.912 | 37.963 | 15.425 | 6.536 |
| Cash | 67 | 17.070 | 28.300 | 21.214 | 9.014 | 30.940 | 16.165 | 8.125 | 12.118 | 30.313 |
| Shareholders Funds | -1.315 | 13.623 | 29.507 | 48.272 | 63.699 | 96.629 | 131.812 | 195.237 | 203.562 | 234.982 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.694 | 31.689 | 32.590 | 5.826 | 144.443 | 136.902 | 247.644 | 313.401 | 290.302 | 296.206 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftalroxmed Srl